The Gist Healthcare Podcast

How the U.S. Supreme Court’s Chevron ruling could impact healthcare. Two decades on, the U.S. has made little progress on addressing health inequities... according to a new report. And HHS and the FBI warn the healthcare sector of certain types of cyberattacks, including phishing schemes. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The Congressional Budget Office projects that the nation’s uninsured rate will rise to nearly 9 percent by 2034. More nurse practitioners are moving into specialty care. And early results from a large clinical trial show a new drug may provide total protection against HIV. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The UAB Health System Authority signs an agreement to acquire Ascension St. Vincent. Missouri joins a growing list of states passing laws to expand 340B drug access. And Teva Pharmaceuticals launches first generic GLP-1 drug in the U.S. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The U.S. Surgeon General declares gun violence a public health crisis. The U.S. Supreme Court agrees to hear a case challenging Tennessee’s ban on gender-affirming care for minors. And HHS finalizes a rule that sets penalties for providers blocking the free exchange of electronic health record data. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

A federal appeals court largely upholds the ACA’s free preventive services mandate. A new study finds that a popular GLP-1 drug may help treat sleep apnea. And more states are expanding Medicaid coverage to hospital at home care. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Risant Health announces its plan to acquire Cone Health. The WHO warns about fake versions of the diabetes drug Ozempic. And federal actuaries project that U.S. healthcare spending will hit nearly $8 trillion by 2032. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The U.S. Supreme Court rejects a case challenging the FDA’s policies on mifepristone. Ascension says protected health data might have been exposed in its recent cyberattack. And the director of CMS’ Innovation Center testifies before a Congressional subcommittee. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The White House teams up with Big Tech to help boost rural hospital cybersecurity.  Insurers get another court win with a recent Medicare Advantage star ratings ruling. And Walgreens-owned CityMD agrees to pay $12 million for alleged COVID payment fraud. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

FDA advisors unanimously recommend approval of Eli Lilly’s Alzheimer’s drug donanemab. The Biden administration proposes a rule to ban medical debt from consumer credit reports. And the U.S. Supreme Court will review a case on Medicare Disproportionate Share Hospital payments. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Moderna reports positive results from its COVID-flu combined vaccine late-stage trial. A new Florida law allows doctors to perform c-sections outside of hospitals. And the American Cancer Society aims to enroll 100,000 Black women in an ambitious new cancer study.  That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.